Source link : https://www.newshealth.biz/health-news/fda-approves-nonstimulant-liquid-onyda-xr-for-adhd/
The US Food and Drug Administration (FDA) has approved Onyda XR (clonidine hydrochloride) for the treatment of attention-deficit/hyperactivity disorder (ADHD), drug manufacturer Tris Pharma announced in a statement. The drug is the first approved liquid nonstimulant ADHD medication. The once-daily extended-release oral suspension, with nighttime dosing, can be used alone or as an adjunctive therapy […]
Author : News Health
Publish date : 2024-05-30 12:46:06
Copyright for syndicated content belongs to the linked Source.
Categories